Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Transcriptional regulation of cuproptosis resistance in cancer therapy

Trends in cancer(2025)10.1016/j.trecan.2025.06.006Source: DataRank Database

Transcriptional regulation of cuproptosis resistance in cancer therapy is a research paper published in Trends in cancer (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.70)OA: greenTopics (24)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Rui Kang ORCID,Daolin Tang ORCID

Live enrichment

PubMed:40571556 PMC:PMC12350063 OpenAlex:https://openalex.org/W4411638123

NCI NIH HHS

Grant: R01 CA160417

NCI NIH HHS

Grant: R01 CA229275

NIH

FWCI

3.70

Citation Percentile

0.9%

Citation Trend

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12350063/

publisherhttps://api.elsevier.com/content/article/PII:S2405803325001487?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2405803325001487?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.trecan.2025.06.006

Fields of Study

Trace Elements in HealthMitochondrial Function and PathologyMetabolomics and Mass Spectrometry Studies

MeSH Terms

AnimalsAntineoplastic AgentsCopperHumansNeoplasmsGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmNF-E2-Related Factor 2Hypoxia-Inducible Factor 1, alpha Subunit

Keywords

Cancer therapyResistance (ecology)CancerBiologyComputational biologyGeneticsEcologyTranscription factorTumor MetabolismTherapy ResistanceCopper MetabolismCuproptosis

Sustainable Development Goals

SDG 0: Good health and well-being